CUTANEOUS T-CELL LYMPHOMA REFRACTORY

CUTANEOUS T-CELL LYMPHOMA REFRACTORY was reported 21 times

CUTANEOUS T-CELL LYMPHOMA REFRACTORY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD30-directed Immunoconjugate [EPC] 5 0.0005
1 Purine Antimetabolite [EPC] 6 0.0001
2 Calcineurin Inhibitor Immunosuppressant [EPC] 6 0.0000
3 Retinoid [EPC] 10 0.0000
4 Folate Analog Metabolic Inhibitor [EPC] 12 0.0000
5 Janus Kinase Inhibitor [EPC] 1 0.0000
6 Alkylating Drug [EPC] 1 0.0000
7 Vitamin D [EPC] 1 0.0000
8 Vitamin B12 [EPC] 1 0.0000
9 Vitamin C [EPC] 1 0.0000
10 Kinase Inhibitor [EPC] 1 0.0000
11 Corticosteroid [EPC] 1 0.0000